# CORRESP — ADMA BIOLOGICS, INC. (ADMA) (CIK 0001368514) > ADMA BIOLOGICS, INC. (ADMA) (CIK 0001368514) → SEC staff · filed 2025-09-26 · ticker ADMA · SIC 2836 ## What is this A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters. ## Key facts - **Accession number:** 0001140361-25-036301 - **Form:** CORRESP - **Filer:** ADMA BIOLOGICS, INC. (ADMA) (CIK 0001368514) - **CIK:** 0001368514 - **Ticker:** ADMA - **Filed:** 2025-09-26 - **SIC industry:** 2836 - **HQ:** Ramsey, NJ ## Primary source PDF letter: https://www.sec.gov/Archives/edgar/data/1368514/000114036125036301/filename1.htm EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1368514&type=UPLOAD&dateb=&owner=include&count=40 ## Other comment-letter activity for ADMA BIOLOGICS, INC. (ADMA) (CIK 0001368514) - UPLOAD — 2025-09-29 — /comment-letter/0000000000-25-010587 - UPLOAD — 2025-09-16 — /comment-letter/0000000000-25-010019 ## Citation > US Securities and Exchange Commission, EDGAR CORRESP comment letter, ADMA BIOLOGICS, INC. (ADMA) (CIK 0001368514) (CIK 0001368514), filed 2025-09-26, accession 0001140361-25-036301. Retrieved via MORVS 2026-11-15 from https://api.morvs.ai/comment-letter/0001140361-25-036301. --- *[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*